TRIVASTAL 50 mg L.P., extended-release coated tablet 30 tablets
Brand page: Trivastal (piribedil) — all forms and strengths in France
Active ingredients: Piribedil
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIVASTAL 50 mg L.P., comprimé enrobé à libération prolongée
- Pharmaceutical form
- comprimé enrobé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 30 comprimé(s)
- Marketing authorisation holder
- LES LABORATOIRES SERVIER
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1977
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61598530CIP73189067CIP133400931890676Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIRIBÉDILcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.